@article{article, title  = {{A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/j.ejca.2024.114009 }},

 year = {{2024}},

 month = {{3}},

 author = {{Sacco JJ and Jackson R and Corrie P and Danson S and Evans TRJ and Ochsenreither S and Kumar S and Goodman A and Larkin J and Karydis I and Steven N et al}},

 doi = {{10.1016/j.ejca.2024.114009}},

 volume = {{202}},

 journal = {{European Journal of Cancer}},

 pages = {{114009-114009}},

 note = {{Accessed on 2024/09/19}}}